Marc Cohen

Marc Cohen has held a variety of executive roles in the technology industry since 1986. Marc began their career as the Founder and former Chairman and CEO of OPNET Technologies Inc., a company they co-founded with their brother Alain. In 2012, OPNET Technologies was sold to Riverbed Technology. Cohen then went on to become the CEO and Co-Founder of Cobro Ventures in 2012, Chairman and Co-Founder of Acetylon in 2008, Chairman and Co-Founder of ONCOPEP in 2014, CEO and Co-Founder of Bublup in 2014, Executive Chairman and Co-Founder of C4 Therapeutics in 2015, and Executive Chairman and Co-Founder of Regenacy Pharmaceuticals in 2016. Marc is currently the Chairman of Frequency Therapeutics.

Marc Cohen attended Harvard University, Stanford University, and Marymount Paris.